http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-102009013469-B4
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5618cd4a81c723091b8f2a4201423860 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-107 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1075 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P23-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-08 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-107 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-33 |
filingDate | 2009-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2014-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a1fb18e4d450701a2092c5e0967c7a6d |
publicationDate | 2014-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | DE-102009013469-B4 |
titleOfInvention | Preparation for external use |
abstract | Preparation for external use in humans and animals comprising in combination a) a composition in the form of a fluid nanophase system comprising the components a1) at least one water-insoluble substance having a water solubility of less than 4 grams per liter, in an amount of from 0.1 to 90% by weight, a2) at least one amphiphilic substance NP-MCA, which has no surfactant structure, is not structure-forming by itself, whose solubility in water or oil is between 4 g and 1000 g per liter and which does not preferentially accumulate at the oil-water interface, in an amount of 0.1 to 80% by weight, a3) at least one anionic, cationic, amphoteric and / or nonionic surfactant; in an amount of 0.1 to 45% by weight, a4) at least one polar protic solvent, in particular with hydroxyl functionality, in an amount between 1.0 and 90% by weight, a5) optionally one or more auxiliaries, in an amount of from 0.01 to 10% by weight, the percentages in each case relating to the total weight of the composition, and b) at least one therapeutically, cosmetically or diagnostically effective agent in a therapeutically, cosmetically or diagnostically effective amount. |
priorityDate | 2009-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1142.